| Guidelines for performing Mendelian randomization investigations: update for summer 2023 S Burgess, GD Smith, NM Davies, F Dudbridge, D Gill, MM Glymour, ... Wellcome open research 4, 186, 2023 | 1700 | 2023 |
| Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches V Zuber, NF Grinberg, D Gill, I Manipur, EAW Slob, A Patel, C Wallace, ... The American Journal of Human Genetics 109 (5), 767-782, 2022 | 291 | 2022 |
| Understanding the consequences of education inequality on cardiovascular disease: mendelian randomisation study AR Carter, D Gill, NM Davies, AE Taylor, T Tillmann, J Vaucher, ... bmj 365, 2019 | 263 | 2019 |
| Genetically determined levels of circulating cytokines and risk of stroke: role of monocyte chemoattractant protein-1 MK Georgakis, D Gill, K Rannikmäe, M Traylor, CD Anderson, ... Circulation 139 (2), 256-268, 2019 | 226 | 2019 |
| Mendelian randomization for studying the effects of perturbing drug targets D Gill, MK Georgakis, VM Walker, AF Schmidt, A Gkatzionis, DF Freitag, ... Wellcome open research 6, 16, 2021 | 197 | 2021 |
| Type 2 diabetes and cancer: an umbrella review of observational and mendelian randomization studies J Pearson-Stuttard, N Papadimitriou, G Markozannes, S Cividini, ... Cancer Epidemiology, Biomarkers & Prevention 30 (6), 1218-1228, 2021 | 196 | 2021 |
| RETRACTED: estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses E Sofianopoulou, SK Kaptoge, S Afzal, T Jiang, D Gill, TE Gundersen, ... The Lancet Diabetes & Endocrinology 9 (12), 837-846, 2021 | 154 | 2021 |
| Use of genetic variants related to antihypertensive drugs to inform on efficacy and side effects D Gill, MK Georgakis, F Koskeridis, L Jiang, Q Feng, WQ Wei, ... Circulation 140 (4), 270-279, 2019 | 147 | 2019 |
| Interleukin-6 signaling effects on ischemic stroke and other cardiovascular outcomes: a Mendelian randomization study MK Georgakis, R Malik, D Gill, N Franceschini, CLM Sudlow, M Dichgans Circulation: Genomic and Precision Medicine 13 (3), e002872, 2020 | 140 | 2020 |
| Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults D Gill, S Derry, PJ Wiffen, RA Moore Cochrane Database of Systematic Reviews, 2011 | 134 | 2011 |
| Cardiometabolic traits, sepsis, and severe COVID-19: a Mendelian randomization investigation MJ Ponsford, A Gkatzionis, VM Walker, AJ Grant, RE Wootton, LSP Moore, ... Circulation 142 (18), 1791-1793, 2020 | 130 | 2020 |
| Genetics of height and risk of atrial fibrillation: a Mendelian randomization study MG Levin, R Judy, D Gill, M Vujkovic, SS Verma, Y Bradford, ... PLoS medicine 17 (10), e1003288, 2020 | 130 | 2020 |
| Mendelian randomization study of obesity and cerebrovascular disease S Marini, J Merino, BE Montgomery, R Malik, CL Sudlow, M Dichgans, ... Annals of neurology 87 (4), 516-524, 2020 | 127 | 2020 |
| A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation M Vujkovic, S Ramdas, KM Lorenz, X Guo, R Darlay, HJ Cordell, J He, ... Nature genetics 54 (6), 761-771, 2022 | 126 | 2022 |
| Clinical trials of immunomodulation in ischemic stroke R Veltkamp, D Gill Neurotherapeutics 13 (4), 791-800, 2016 | 124 | 2016 |
| Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study S Yuan, J Chen, X Li, R Fan, B Arsenault, D Gill, EL Giovannucci, J Zheng, ... European journal of epidemiology 37 (7), 723-733, 2022 | 123 | 2022 |
| Dynamics of T cell responses after stroke D Gill, R Veltkamp Current opinion in pharmacology 26, 26-32, 2016 | 123 | 2016 |
| Genetic determinants of lipids and cardiovascular disease outcomes: a wide-angled Mendelian randomization investigation E Allara, G Morani, P Carter, A Gkatzionis, V Zuber, CN Foley, JMB Rees, ... Circulation: Genomic and Precision Medicine 12 (12), e002711, 2019 | 121 | 2019 |
| Obesity, type 2 diabetes, lifestyle factors, and risk of gallstone disease: a Mendelian randomization investigation S Yuan, D Gill, EL Giovannucci, SC Larsson Clinical gastroenterology and hepatology 20 (3), e529-e537, 2022 | 116 | 2022 |
| Urate, blood pressure, and cardiovascular disease: evidence from mendelian randomization and meta-analysis of clinical trials D Gill, AC Cameron, S Burgess, X Li, DJ Doherty, V Karhunen, ... Hypertension 77 (2), 383-392, 2021 | 116 | 2021 |